Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;21(2):202-24.
doi: 10.1016/j.bbmt.2014.10.003. Epub 2014 Oct 15.

Blood and marrow transplant clinical trials network state of the Science Symposium 2014

Frederick R Appelbaum  1 , Claudio Anasetti  2 , Joseph H Antin  3 , Harold Atkins  4 , Stella Davies  5 , Steven Devine  6 , Sergio Giralt  7 , Helen Heslop  8 , Ginna Laport  9 , Stephanie J Lee  10 , Brent Logan  11 , Marcelo Pasquini  11 , Michael Pulsipher  12 , Edward Stadtmauer  13 , John R Wingard  14 , Mary M Horowitz  11
Affiliations

Blood and marrow transplant clinical trials network state of the Science Symposium 2014

Frederick R Appelbaum et al. Biol Blood Marrow Transplant. 2015 Feb.
No abstract available

Keywords: Hematopoietic cell transplantation; Leukemia; Lymphoma; Myeloma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: There are no conflicts of interest to report.

Figures

Figure 1
Figure 1
The overall trial design depends on assignment to a high- or low-risk group based on GVHD grade and biomarkers. High-risk patients will be treated with prednisone, and new agents will be serially studied by addition to standard prednisone therapy. Low-risk patients will be randomized between a prednisone monotherapy or 1 of several single-agent nonsteroid alternatives.
See this image and copyright information in PMC

References

    1. Ferrara JL, Anasetti C, Stadtmauer E, et al. Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Biol Blood Marrow Transplant. 2007;13:1268–1285. - PubMed
    1. Ferrara JL. Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007. Biol Blood Marrow Transplant. 2014;20:149–153. - PMC - PubMed
    1. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059–2074. - PMC - PubMed
    1. Pratcorona M, Brunet S, Nomdedeu J, et al. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. Blood. 2013;121:2734–2738. - PubMed
    1. Swords R, Freeman C, Giles F. Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia (Review) Leukemia. 2012;26:2176–2185. - PubMed

Publication types

MeSH terms